DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 573
[Docket No. FDA-2013-F-1539]
DSM Nutritional Products, Inc.; Withdrawal of Food Additive Petition (Animal Use)
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notification; withdrawal of petition for rulemaking.
SUMMARY:
The Food and Drug Administration (FDA or we) is announcing the withdrawal, without prejudice to a future filing, of a food additive petition (animal use) (FAP 2276) proposing that the food additive regulations be amended to provide for the safe use of ethoxyquin in vitamin D formulations, including 25-hydroxyvitamin D
3
, used in animal food.
DATES:
The food additive petition was withdrawn on September 13, 2017.
ADDRESSES:
For access to the docket to read background documents or comments received, go to
https://www.regulations.gov
and insert the docket number, found in brackets in the heading of this document, into the “Search” box and follow the prompts; and/or go to the Dockets Management Staff, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT:
Chelsea Trull, Center for Veterinary Medicine, Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-402-6729,
chelsea.trull@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
In a notice published in the
Federal Register
of December 23, 2013 (78 FR 77384), we announced that we had filed a food additive petition (FAP 2276), submitted by DSM Nutritional Products, 45 Waterview Blvd., Parsippany, NJ 07054. The petition proposed to amend the food additive regulations in 21 CFR part 573
Food Additives Permitted in Feed and Drinking Water of Animals
to provide for the safe use of ethoxyquin as a chemical preservative in vitamin D formulations, including 25-hydroxyvitamin D
3,
used in animal food. DSM Nutritional Products, Inc., has now withdrawn the petition without prejudice to a future filing (21 CFR 571.7).
Dated: October 26, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning, Legislation, and Analysis.